This course reviews new topical therapies for presbyopia and dry eye disease, including pilocarpine 0.4%, aceclidine, and TRPM8 agonists. Mechanisms of action, clinical trial outcomes, safety profiles, and patient selection strategies will be discussed to help clinicians integrate these therapies into contemporary anterior segment care.